OrganiGram Total Current Liabilities vs Common Stock Analysis

OGI Stock

USD 1.76 0.04 2.22%

OrganiGram Holdings financial indicator trend analysis is much more than just breaking down OrganiGram Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OrganiGram Holdings is a good investment. Please check the relationship between OrganiGram Holdings Total Current Liabilities and its Common Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

Total Current Liabilities vs Common Stock

Total Current Liabilities vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OrganiGram Holdings Total Current Liabilities account and Common Stock. At this time, the significance of the direction appears to have strong relationship.

The correlation between OrganiGram Holdings' Total Current Liabilities and Common Stock is 0.71. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Common Stock in the same time period over historical financial statements of OrganiGram Holdings, assuming nothing else is changed. The correlation between historical values of OrganiGram Holdings' Total Current Liabilities and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of OrganiGram Holdings are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Total Current Liabilities i.e., OrganiGram Holdings' Total Current Liabilities and Common Stock go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on OrganiGram Holdings balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of OrganiGram Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock

Most indicators from OrganiGram Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OrganiGram Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.The OrganiGram Holdings' current Selling General Administrative is estimated to increase to about 59.1 M, while Discontinued Operations is projected to decrease to (35.9 K).

	2023	2024 (projected)
Reconciled Depreciation	28.6M	16.1M
Interest Income	11.8M	12.4M

Reconciled Depreciation Interest Income

OrganiGram Holdings fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Property Plant And Equipment Net	Accounts Payable	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Common Stock	Short Long Term Debt Total	Net Tangible Assets	Long Term Debt	Short Term Investments	Long Term Debt Total
Total Assets		0.15	0.92	0.99	-0.26	-0.55	0.93	0.98	0.47	0.81	0.78	0.74	0.78	0.8	0.97	0.97	0.93	0.86	0.55	0.75	0.76	0.34	0.99	0.3	0.65	0.75
Other Current Liab	0.15		0.28	0.23	-0.79	-0.12	0.3	0.17	0.35	0.11	0.31	0.2	0.03	-0.21	0.12	0.04	0.17	0.03	-0.41	0.22	0.18	-0.59	0.19	-0.6	-0.04	-0.06
Total Current Liabilities	0.92	0.28		0.92	-0.32	-0.49	0.85	0.95	0.41	0.55	0.82	0.68	0.68	0.68	0.84	0.92	0.99	0.8	0.36	0.68	0.71	0.23	0.91	0.19	0.32	0.59
Total Stockholder Equity	0.99	0.23	0.92		-0.38	-0.61	0.92	0.98	0.52	0.78	0.83	0.77	0.77	0.7	0.95	0.94	0.92	0.87	0.42	0.76	0.81	0.2	0.99	0.16	0.63	0.68
Net Debt	-0.26	-0.79	-0.32	-0.38		0.51	-0.32	-0.3	-0.48	-0.16	-0.54	-0.46	-0.25	0.3	-0.21	-0.14	-0.23	-0.3	0.57	-0.3	-0.51	0.79	-0.37	0.81	-0.12	0.09
Retained Earnings	-0.55	-0.12	-0.49	-0.61	0.51		-0.49	-0.53	-0.09	-0.3	-0.87	-0.94	-0.86	-0.15	-0.55	-0.45	-0.5	-0.85	0.14	-0.76	-0.94	0.22	-0.64	0.26	-0.39	-0.41
Cash	0.93	0.3	0.85	0.92	-0.32	-0.49		0.87	0.43	0.82	0.73	0.7	0.77	0.77	0.96	0.84	0.84	0.75	0.55	0.73	0.7	0.33	0.91	0.28	0.62	0.85
Non Current Assets Total	0.98	0.17	0.95	0.98	-0.3	-0.53	0.87		0.54	0.74	0.8	0.71	0.72	0.74	0.91	0.98	0.95	0.85	0.46	0.7	0.76	0.27	0.98	0.23	0.57	0.63
Non Currrent Assets Other	0.47	0.35	0.41	0.52	-0.48	-0.09	0.43	0.54		0.55	0.3	0.16	0.06	0.16	0.37	0.46	0.33	0.2	0.04	0.13	0.24	-0.19	0.47	-0.2	0.43	0.04
Cash And Short Term Investments	0.81	0.11	0.55	0.78	-0.16	-0.3	0.82	0.74	0.55		0.43	0.5	0.58	0.75	0.85	0.74	0.56	0.58	0.66	0.59	0.52	0.38	0.78	0.35	0.93	0.73
Net Receivables	0.78	0.31	0.82	0.83	-0.54	-0.87	0.73	0.8	0.3	0.43		0.94	0.88	0.4	0.72	0.73	0.8	0.92	0.02	0.82	0.95	-0.09	0.84	-0.13	0.35	0.5
Common Stock Shares Outstanding	0.74	0.2	0.68	0.77	-0.46	-0.94	0.7	0.71	0.16	0.5	0.94		0.95	0.41	0.74	0.66	0.69	0.95	0.09	0.9	0.99	-0.04	0.81	-0.08	0.51	0.59
Other Stockholder Equity	0.78	0.03	0.68	0.77	-0.25	-0.86	0.77	0.72	0.06	0.58	0.88	0.95		0.6	0.82	0.7	0.71	0.94	0.33	0.87	0.93	0.23	0.82	0.18	0.56	0.78
Total Liab	0.8	-0.21	0.68	0.7	0.3	-0.15	0.77	0.74	0.16	0.75	0.4	0.41	0.6		0.83	0.83	0.74	0.6	0.91	0.53	0.4	0.81	0.72	0.78	0.57	0.84
Total Current Assets	0.97	0.12	0.84	0.95	-0.21	-0.55	0.96	0.91	0.37	0.85	0.72	0.74	0.82	0.83		0.9	0.86	0.84	0.62	0.79	0.75	0.41	0.95	0.36	0.72	0.86
Property Plant And Equipment Net	0.97	0.04	0.92	0.94	-0.14	-0.45	0.84	0.98	0.46	0.74	0.73	0.66	0.7	0.83	0.9		0.94	0.83	0.57	0.68	0.69	0.4	0.95	0.37	0.57	0.64
Accounts Payable	0.93	0.17	0.99	0.92	-0.23	-0.5	0.84	0.95	0.33	0.56	0.8	0.69	0.71	0.74	0.86	0.94		0.83	0.43	0.7	0.71	0.31	0.92	0.27	0.35	0.62
Common Stock Total Equity	0.86	0.03	0.8	0.87	-0.3	-0.85	0.75	0.85	0.2	0.58	0.92	0.95	0.94	0.6	0.84	0.83	0.83		0.29	0.88	0.96	0.17	0.91	0.12	0.56	0.64
Non Current Liabilities Total	0.55	-0.41	0.36	0.42	0.57	0.14	0.55	0.46	0.04	0.66	0.02	0.09	0.33	0.91	0.62	0.57	0.43	0.29		0.26	0.07	0.93	0.43	0.92	0.54	0.76
Property Plant And Equipment Gross	0.75	0.22	0.68	0.76	-0.3	-0.76	0.73	0.7	0.13	0.59	0.82	0.9	0.87	0.53	0.79	0.68	0.7	0.88	0.26		0.86	0.14	0.79	0.09	0.58	0.64
Common Stock	0.76	0.18	0.71	0.81	-0.51	-0.94	0.7	0.76	0.24	0.52	0.95	0.99	0.93	0.4	0.75	0.69	0.71	0.96	0.07	0.86		-0.07	0.84	-0.12	0.52	0.55
Short Long Term Debt Total	0.34	-0.59	0.23	0.2	0.79	0.22	0.33	0.27	-0.19	0.38	-0.09	-0.04	0.23	0.81	0.41	0.4	0.31	0.17	0.93	0.14	-0.07		0.22	1.0	0.28	0.64
Net Tangible Assets	0.99	0.19	0.91	0.99	-0.37	-0.64	0.91	0.98	0.47	0.78	0.84	0.81	0.82	0.72	0.95	0.95	0.92	0.91	0.43	0.79	0.84	0.22		0.17	0.65	0.69
Long Term Debt	0.3	-0.6	0.19	0.16	0.81	0.26	0.28	0.23	-0.2	0.35	-0.13	-0.08	0.18	0.78	0.36	0.37	0.27	0.12	0.92	0.09	-0.12	1.0	0.17		0.25	0.6
Short Term Investments	0.65	-0.04	0.32	0.63	-0.12	-0.39	0.62	0.57	0.43	0.93	0.35	0.51	0.56	0.57	0.72	0.57	0.35	0.56	0.54	0.58	0.52	0.28	0.65	0.25		0.62
Long Term Debt Total	0.75	-0.06	0.59	0.68	0.09	-0.41	0.85	0.63	0.04	0.73	0.5	0.59	0.78	0.84	0.86	0.64	0.62	0.64	0.76	0.64	0.55	0.64	0.69	0.6	0.62

Click cells to compare fundamentals

OrganiGram Holdings Account Relationship Matchups

OrganiGram Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	417.6M	554.0M	577.1M	298.5M	343.2M	251.2M
Other Current Liab	(11.6M)	2.8M	11.0M	1.2M	1.4M	1.6M
Total Current Liabilities	29.1M	26.3M	55.3M	22.4M	25.8M	18.3M
Total Stockholder Equity	299.5M	479.8M	508.1M	271.6M	312.4M	202.3M
Net Debt	79.1M	(50.4M)	(65.2M)	(29.1M)	(26.2M)	(24.9M)
Retained Earnings	(144.9M)	(275.6M)	(289.9M)	(538.5M)	(484.7M)	(460.4M)
Cash	24.6M	55.4M	68.5M	33.9M	38.9M	27.4M
Non Current Assets Total	247.4M	293.4M	355.5M	142.5M	163.9M	144.2M
Non Currrent Assets Other	8.0M	31.1M	32.4M	613K	705.0K	669.7K
Cash And Short Term Investments	74.7M	183.8M	98.9M	33.9M	38.9M	58.5M
Net Receivables	17.0M	21.0M	46.1M	30.2M	34.7M	36.4M
Common Stock Shares Outstanding	43.2M	64.0M	77.2M	81.3M	93.5M	98.2M
Liabilities And Stockholders Equity	417.6M	554.0M	577.1M	298.5M	343.2M	251.2M
Other Stockholder Equity	23.7M	24.7M	28.3M	33.2M	38.2M	40.1M
Total Liab	118.1M	74.2M	69.0M	26.8M	30.9M	48.9M
Total Current Assets	170.2M	260.6M	221.6M	156.0M	179.4M	119.0M
Property Plant And Equipment Net	247.4M	235.9M	259.8M	99.0M	113.9M	135.1M
Accounts Payable	29.1M	23.4M	40.9M	20.0M	23.0M	17.5M
Non Current Liabilities Total	89.0M	47.9M	13.8M	4.4M	5.1M	4.8M
Accumulated Other Comprehensive Income	23.8M	24.6M	28.3M	33.2M	38.2M	40.1M
Common Stock	420.7M	730.8M	769.7M	776.9M	893.4M	938.1M
Short Long Term Debt Total	103.7M	5.0M	3.4M	4.7M	4.2M	4.0M
Other Liab	231K	43.1M	11.4M	771K	886.7K	842.3K
Net Tangible Assets	297.8M	462.8M	451.8M	261.0M	300.1M	258.4M
Other Assets	8.7M	35.4M	33.1M	1.0	1.15	1.09
Long Term Debt	46.1M	103.7M	230K	155K	178.3K	169.3K
Short Term Investments	380K	50.1M	128.5M	30.4M	35.0M	46.6M
Inventory	71.8M	48.8M	68.3M	81.0M	93.1M	56.5M
Other Current Assets	23.7M	7.0M	8.4M	11.0M	12.7M	11.5M
Deferred Long Term Liab	698K	7K	30K	391K	449.7K	354.3K
Long Term Investments	11.1M	7.0M	6.1M	7.1M	8.1M	4.3M
Short Long Term Debt	421K	3.5M	11.6M	80K	92K	87.4K
Short Term Debt	11.6M	80K	996K	1.1M	1.3M	2.3M
Intangible Assets	1.8M	2.7M	14.3M	10.6M	12.2M	12.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:

How To Invest In OrganiGram

Details

Is OrganiGram Stock a good investment?

Details

What is OrganiGram Holdings' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

Note that the OrganiGram Holdings information on this page should be used as a complementary analysis to other OrganiGram Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for OrganiGram Stock analysis

When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.

	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Global Correlations Find global opportunities by holding instruments from different markets

Is OrganiGram Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.83)

Revenue Per Share

1.835

Quarterly Revenue Growth

(0.14)

Return On Assets

(0.06)

Return On Equity

(0.55)

The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

OrganiGram Total Current Liabilities vs Common Stock Analysis

Total Current Liabilities vs Common Stock

Total Current Liabilities vs Common Stock Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Common Stock

OrganiGram Holdings fundamental ratios Correlations

OrganiGram Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

OrganiGram Holdings fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for OrganiGram Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Total Stockholder Equity	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Total Current Liabilities
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Shares Outstanding

Common Stock	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Net Receivables	- 0.87	Retained Earnings
Other Stockholder Equity	- 0.86	Retained Earnings
Common Stock Total Equity	- 0.85	Retained Earnings
Net Debt	- 0.79	Other Current Liab